# Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients

> **NCT01610141** · PHASE4 · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Atrial Fibrillation
- Deep Vein Thrombosis
- Pulmonary Embolism
- Heart Valve Disease

## Interventions

- **OTHER:** Genotype-guided warfarin dosing
- **OTHER:** Non-genotype guided warfarin dosing

## Key facts

- **NCT ID:** NCT01610141
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-06
- **Primary completion:** 2014-06
- **Final completion:** 2015-06
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2013-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01610141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01610141, "Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01610141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*